Neuphoria Therapeutics In... (NEUP)
NASDAQ: NEUP
· Real-Time Price · USD
12.31
-0.14 (-1.12%)
At close: Sep 26, 2025, 3:59 PM
12.55
1.95%
After-hours: Sep 26, 2025, 07:47 PM EDT
-1.12% (1D)
| Bid | 11.47 |
| Market Cap | 23.14M |
| Revenue (ttm) | 15.66M |
| Net Income (ttm) | 5.74M |
| EPS (ttm) | 18.83 |
| PE Ratio (ttm) | 0.65 |
| Forward PE | -2.95 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 13.15 |
| Volume | 50,294 |
| Avg. Volume (20D) | 57,415 |
| Open | 12.96 |
| Previous Close | 12.45 |
| Day's Range | 12.13 - 13.28 |
| 52-Week Range | 2.12 - 15.14 |
| Beta | 0.58 |
| Ex-Dividend Date | n/a |
About NEUP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NEUP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NEUP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
Neuphoria Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
4 months ago · https://www.marketscreener.com
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual MeetingBURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments fo...